253 related articles for article (PubMed ID: 8341892)
21. Insomnia in generalized anxiety disorder: polysomnographic, psychometric and clinical investigations before, during and after therapy with a long- versus a short-half-life benzodiazepine (quazepam versus triazolam).
Saletu B; Anderer P; Brandstätter N; Frey R; Grünberger J; Klösch G; Mandl M; Wetter T; Zeitlhofer J
Neuropsychobiology; 1994; 29(2):69-90. PubMed ID: 8170529
[TBL] [Abstract][Full Text] [Related]
22. Multidrug comparison (lorazepam, triazolam, zolpidem, and zopiclone) in situational insomnia: polysomnographic analysis by means of the cyclic alternating pattern.
Parrino L; Boselli M; Spaggiari MC; Smerieri A; Terzano MG
Clin Neuropharmacol; 1997 Jun; 20(3):253-63. PubMed ID: 9197949
[TBL] [Abstract][Full Text] [Related]
23. Effect of triazolam on sleep and arterial oxygen saturation in patients with chronic obstructive pulmonary disease.
Timms RM; Dawson A; Hajdukovic RM; Mitler MM
Arch Intern Med; 1988 Oct; 148(10):2159-63. PubMed ID: 3178373
[TBL] [Abstract][Full Text] [Related]
24. Effects of flurazepam and zolpidem on the perception of sleep in normal volunteers.
Mendelson WB
Sleep; 1995 Feb; 18(2):88-91. PubMed ID: 7792497
[TBL] [Abstract][Full Text] [Related]
25. [Contribution of zolpidem in the management of sleep disorders].
Lavoisy J; Zivkovic B; Benavides J; Perrault GH; Robert P
Encephale; 1992; 18(4):379-92. PubMed ID: 1363657
[TBL] [Abstract][Full Text] [Related]
26. Triazolam in patients with obstructive sleep apnea.
Berry RB; Kouchi K; Bower J; Prosise G; Light RW
Am J Respir Crit Care Med; 1995 Feb; 151(2 Pt 1):450-4. PubMed ID: 7842205
[TBL] [Abstract][Full Text] [Related]
27. Sleep and residual sedation after administration of zaleplon, zolpidem, and placebo during experimental middle-of-the-night awakening.
Zammit GK; Corser B; Doghramji K; Fry JM; James S; Krystal A; Mangano RM
J Clin Sleep Med; 2006 Oct; 2(4):417-23. PubMed ID: 17557470
[TBL] [Abstract][Full Text] [Related]
28. Dose response effects of zolpidem in normal geriatric subjects.
Scharf MB; Mayleben DW; Kaffeman M; Krall R; Ochs R
J Clin Psychiatry; 1991 Feb; 52(2):77-83. PubMed ID: 1993640
[TBL] [Abstract][Full Text] [Related]
29. Zolpidem-polysomnographic study of the effect of a new hypnotic drug in sleep apnea syndrome.
Cirignotta F; Mondini S; Zucconi M; Gerardi R; Farolfi A; Lugaresi E
Pharmacol Biochem Behav; 1988 Apr; 29(4):807-9. PubMed ID: 3413202
[TBL] [Abstract][Full Text] [Related]
30. Pilot controlled double-blind study of the hypnotic effects of zolpidem in patients with chronic 'learned' insomnia: psychometric and polysomnographic evaluation.
Herrmann WM; Kubicki ST; Boden S; Eich FX; Attali P; Coquelin JP
J Int Med Res; 1993; 21(6):306-22. PubMed ID: 8143886
[TBL] [Abstract][Full Text] [Related]
31. Zolpidem in the treatment of transient insomnia: a double-blind, randomized comparison with placebo.
Roth T; Roehrs T; Vogel G
Sleep; 1995 May; 18(4):246-51. PubMed ID: 7618022
[TBL] [Abstract][Full Text] [Related]
32. Comparison of the daytime sleep and performance effects of zolpidem versus triazolam.
Balkin TJ; O'Donnell VM; Wesensten N; McCann U; Belenky G
Psychopharmacology (Berl); 1992; 107(1):83-8. PubMed ID: 1589566
[TBL] [Abstract][Full Text] [Related]
33. Improved insomnia symptoms and sleep-related next-day functioning in patients with comorbid major depressive disorder and insomnia following concomitant zolpidem extended-release 12.5 mg and escitalopram treatment: a randomized controlled trial.
Fava M; Asnis GM; Shrivastava RK; Lydiard B; Bastani B; Sheehan DV; Roth T
J Clin Psychiatry; 2011 Jul; 72(7):914-28. PubMed ID: 21208597
[TBL] [Abstract][Full Text] [Related]
34. The effect of triazolam and flunitrazepam--two benzodiazepines with different half-lives--on breathing during sleep.
Schneider H; Grote L; Peter JH; Cassel W; Guilleminault C
Chest; 1996 Apr; 109(4):909-15. PubMed ID: 8635369
[TBL] [Abstract][Full Text] [Related]
35. Zolpidem for persistent insomnia in SSRI-treated depressed patients.
Asnis GM; Chakraburtty A; DuBoff EA; Krystal A; Londborg PD; Rosenberg R; Roth-Schechter B; Scharf MB; Walsh JK
J Clin Psychiatry; 1999 Oct; 60(10):668-76. PubMed ID: 10549683
[TBL] [Abstract][Full Text] [Related]
36. The selective extrasynaptic GABAA agonist, gaboxadol, improves traditional hypnotic efficacy measures and enhances slow wave activity in a model of transient insomnia.
Walsh JK; Deacon S; Dijk DJ; Lundahl J
Sleep; 2007 May; 30(5):593-602. PubMed ID: 17552374
[TBL] [Abstract][Full Text] [Related]
37. Placebo-controlled sleep laboratory studies on the acute effects of zolpidem on objective and subjective sleep and awakening quality in nonorganic insomnia related to neurotic and stress-related disorder.
Saletu-Zyhlarz G; Anderer P; Brandstätter N; Dantendorfer K; Gruber G; Mandl M; Ritter K; Zoghlami A; Saletu B
Neuropsychobiology; 2000; 41(3):139-48. PubMed ID: 10754428
[TBL] [Abstract][Full Text] [Related]
38. Effects of triazolam on sleep, daytime sleepiness, and morning stiffness in patients with rheumatoid arthritis.
Walsh JK; Muehlbach MJ; Lauter SA; Hilliker NA; Schweitzer PK
J Rheumatol; 1996 Feb; 23(2):245-52. PubMed ID: 8882027
[TBL] [Abstract][Full Text] [Related]
39. Zolpidem: distinct from triazolam?
Lobo BL; Greene WL
Ann Pharmacother; 1997 May; 31(5):625-32. PubMed ID: 9161660
[TBL] [Abstract][Full Text] [Related]
40. Long-term, non-nightly administration of zolpidem in the treatment of patients with primary insomnia.
Perlis ML; McCall WV; Krystal AD; Walsh JK
J Clin Psychiatry; 2004 Aug; 65(8):1128-37. PubMed ID: 15323600
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
